SCHEMBL13465385

SCHEMBL13465385

CC(CNC(=O)[C@@H]1C[C@H](C)CC[C@H]1C(C)C)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.60
TRPM8 Q7Z2W7 5/20 0.50
EPHX1 P07099 1/20 0.46
MEN1 O00255 1/20 0.45
NTSR1 P30989 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
KCNA5 P22460 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
P2RX4 Q99571 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
TP53 P04637 2/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2628652 1.00 TAAR1 (0.60) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL24540270 1.00 TAAR1 (0.60) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL2628665 1.00 TAAR1 (0.60) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL2628727 0.91 TRPM8 (0.51) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL2628626 0.89 TRPM8 (0.52) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL2628627 0.89 TRPM8 (0.52) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL29112425 0.89 TRPM8 (0.52) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL18786371 0.89 TRPM8 (0.52) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL24540582 0.89 TRPM8 (0.52) TAAR1TRPM8EPHX1MEN1NTSR1
SCHEMBL2628609 0.89 TRPM8 (0.52) TAAR1TRPM8EPHX1MEN1NTSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200138764-A1 METHODS AND DEVICES FOR ACTIVATING ADIPOSE TISSUE THE PROCTER & GAMBLE COMPANY 2020-05-07 US disclosed
US-20170057911-A1 SYNTHESIS OF ARYL CYCLOHEXANE CARBOXAMIDE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS PROCTER & GAMBLE (US) 2017-03-02 US disclosed
EP-2510925-A2 Small-Molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2012-10-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200138764-A1 METHODS AND DEVICES FOR ACTIVATING ADIPOSE TISSUE LRBA, FABP4, LIPE TAAR1 3380/4885TRPM8 138/4885EPHX1 1278/4885
US-20170057911-A1 SYNTHESIS OF ARYL CYCLOHEXANE CARBOXAMIDE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS CUTA, ACMSD, SRM TAAR1 110/4885TRPM8 376/4885EPHX1 4153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.